Boston Scientific shares fall after FY26/Q3 guidance outlook cut
Boston Scientific said it is unlikely to meet FY26 and Q3 adjusted EPS and net sales growth guidance after a previously announced cybersecurity incident affected operations.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.